Trials / Recruiting
RecruitingNCT03696680
Stereotactic Radiotherapy for Cerebral Metastases with Recent Hemorrhagic Signal
Stereotactic Radiotherapy for Cerebral Metastases with Recent Hemorrhagic Signal: Phase 2 Study in 2 Steps
- Status
- Recruiting
- Phase
- Phase 2
- Study type
- Interventional
- Enrollment
- 46 (estimated)
- Sponsor
- Centre Francois Baclesse · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
This prospective 2-stage, non-randomized Phase 2 trial evaluates the safety and efficacy of FSRT for the management of hemorrhagic brain metastases
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| RADIATION | FSRT Stereotactic radiation therapy | For each metastasis, dose of 30 Gy in 3 fractions at 10 Gy / fraction over 7 days |
Timeline
- Start date
- 2019-01-16
- Primary completion
- 2027-06-01
- Completion
- 2028-01-01
- First posted
- 2018-10-05
- Last updated
- 2025-02-11
Locations
4 sites across 1 country: France
Source: ClinicalTrials.gov record NCT03696680. Inclusion in this directory is not an endorsement.